[Federal Register Volume 70, Number 104 (Wednesday, June 1, 2005)]
[Rules and Regulations]
[Pages 31365-31370]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-10845]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 180

[OPP-2005-0115; FRL-7712-1]


Two Isopropylamine Salts of Alkyl C4 and Alkyl 
C8- 10 Ethoxyphosphate esters; Exemption from the 
Requirement of a Tolerance

AGENCY: Environmental Protection Agency (EPA).

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This regulation establishes two exemptions from the 
requirement of a tolerance for residues of 2-propanamine, compound with 
[alpha]-phosphono- [omega] -butoxypoly (oxy-1,2-ethanediyl) (2:1) and 
2-propanamine, compounds with polyethylene glycol dihydrogen phosphate 
C8- 10- alkyl ether (2:1), referred to as 2 isopropylamine 
salts of alkyl C4 and alkyl C8- 10 
ethoxyphosphate esters, when used as inert ingredients (emulsifier, 
solvent and cosolvent) in pesticide formulations applied only to 
growing crops. Rhodia, Inc, CN 7500, Cranbury, NJ 08512-7500, submitted 
a petition to EPA under the Federal Food, Drug, and Cosmetic Act 
(FFDCA), as amended by the Food Quality Protection Act of 1996 (FQPA), 
requesting an exemption from the requirement of a tolerance. This 
regulation eliminates the need to establish a maximum permissible level 
for residues of these two chemicals.

DATES: This regulation is effective June 1, 2005. Objections and 
requests for hearings must be received on or before August 1, 2005.

ADDRESSES: To submit a written objection or hearing request follow the 
detailed instructions as provided in Unit XI. of the SUPPLEMENTARY 
INFORMATION. EPA has established a docket for this action under Docket 
identification (ID) number OPP-2005-0115. All documents in the docket 
are listed in the EDOCKET index at http://www.epa.gov/edocket. Although 
listed in the index, some information is not publicly available, i.e., 
CBI or other information whose disclosure is restricted by statute. 
Certain other material, such as copyrighted material, is not placed on 
the Internet and will be publicly available only in hard copy form. 
Publicly available docket materials are available either electronically 
in EDOCKET or in hard copy at the Public Information and Records 
Integrity Branch (PIRIB), Rm. 119, Crystal Mall 2, 1801 S. 
Bell St., Arlington, VA. This docket facility is open from 8:30 a.m. to 
4 p.m., Monday through Friday, excluding legal holidays. The docket 
telephone number is (703) 305-5805.

FOR FURTHER INFORMATION CONTACT: Princess Campbell, Registration 
Division (7505C), Office of Pesticide Programs, Environmental 
Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-
0001; telephone number: (703) 308-8033; e-mail address: 
[email protected].

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this Action Apply to Me?

    You may be potentially affected by this action if you are an 
agricultural producer, food manufacturer, or pesticide manufacturer. 
Potentially affected entities may include, but are not limited to:
     Crop production (NAICS code 111)
     Animal production (NAICS code 112)
     Food manufacturing (NAICS code 311)
     Pesticide manufacturing (NAICS code 32532)
    This listing is not intended to be exhaustive, but rather provides 
a guide for readers regarding entities likely to be affected by this 
action. Other types of entities not listed in this unit could also be 
affected. The North American Industrial Classification System (NAICS) 
codes have been provided to assist you and others in determining 
whether this action might apply to certain entities. If you have any 
questions regarding the applicability of this action to a particular 
entity, consult the person listed under FOR FURTHER INFORMATION 
CONTACT.
    This listing is not intended to be exhaustive, but rather provides 
a guide for readers regarding entities likely to be affected by this 
action. Other types of entities not listed in this unit could also be 
affected. The North American Industrial Classification System (NAICS) 
codes have been provided to assist you and others in determining 
whether this action might apply to certain entities. If you have any 
questions regarding the applicability of this action to a particular 
entity, consult the person listed under FOR FURTHER INFORMATION 
CONTACT.

B. How Can I Get Electronic Documents and Other Related Information?

    In addition to using EDOCKET at (http://www.epa.gov/edocket/), you 
may access this Federal Register document electronically through the 
EPA Internet under the ``Federal Register'' listings at http://www.epa.gov/fedrgstr/. A frequently updated electronic version of 40 
CFR part 180 is available at E-CFR Beta Site Two at http://www.gpoaccess.gov/ecfr/.

II. Background and Statutory Findings

    In the Federal Register of March 17, 1999 (64 FR 13195) (FRL-6065-
5) EPA issued a notice pursuant to section 408 of the FFDCA, 21 U.S.C. 
346a, as amended by the FQPA (Public Law 104-170), announcing the 
filing of pesticide petitions (PP 8E4990 and 8E4956) by Rhodia Inc, CN 
7500, Cranbury, NJ 08512-7500.
    The petitions requested that 40 CFR 180.1001(d) newly re-designated 
as 40 CFR 180.920 be amended to include exemptions from the requirement 
of a tolerance for residues of 2-Propanamine, compound with [alpha]-
phosphono- [omega]- butoxypoly (oxy-1,2-ethanediyl) (2:1) (CAS Reg. No. 
43140-31-2) and 2-Propanamine, compounds with polyethylene glycol 
dihydrogen phosphate C8- 10- alkyl ether (2:1) (CAS Reg. No. 
431062-72-5). The 1999 notice included a summary of the petition 
prepared by the petitioner requesting, to amend 40 CFR part 180 to 
establish an exemption from the requirement of a tolerance for these 
two chemicals when used as inert ingredients in pesticide formulations 
applied only to growing crops. There were no comments received in 
response to the notice of filing.
    Section 408(b)(2)(A)(i) of the FFDCA allows EPA to establish an 
exemption from the requirement for a tolerance (the legal limit for a 
pesticide chemical residue in or on a food) only if EPA determines that 
the tolerance is ``safe.'' Section 408(b)(2)(A)(ii) of the FFDCA 
defines ``safe'' to mean that ``there is a reasonable certainty that no 
harm will result from aggregate exposure to the pesticide chemical 
residue, including all anticipated dietary exposures and all other 
exposures for which there is reliable information.'' This includes 
exposure through drinking water and in residential settings, but does 
not include occupational exposure. Section 408(b)(2)(C) of the FFDCA 
requires EPA to give special consideration to exposure of infants and 
children to the pesticide chemical residue in establishing a tolerance 
and to ``ensure that there is a reasonable certainty that no harm will 
result to infants and children from aggregate exposure to the pesticide 
chemical residue. . . .''
    EPA performs a number of analyses to determine the risks from 
aggregate

[[Page 31366]]

exposure to pesticide residues. First, EPA determines the toxicity of 
pesticides. Second, EPA examines exposure to the pesticide through 
food, drinking water, and through other exposures that occur as a 
result of pesticide use in residential settings.

III. Inert Ingredient Definition

    Inert ingredients are all ingredients that are not active 
ingredients as defined in 40 CFR 153.125 and include, but are not 
limited to, the following types of ingredients (except when they have a 
pesticidal efficacy of their own): Solvents such as alcohols and 
hydrocarbons; surfactants such as polyoxyethylene polymers and fatty 
acids; carriers such as clay and diatomaceous earth; thickeners such as 
carrageenan and modified cellulose; wetting, spreading, and dispersing 
agents; propellants in aerosol dispensers; microencapsulating agents; 
and emulsifiers. The term ``inert'' is not intended to imply 
nontoxicity; the ingredient may or may not be chemically active. 
Generally, EPA has exempted inert ingredients from the requirement of a 
tolerance based on the low toxicity of the individual inert 
ingredients.

IV. Toxicological Profile

    Consistent with section 408(b)(2)(D) of the FFDCA, EPA has reviewed 
the available scientific data and other relevant information in support 
of this action and considered its validity, completeness and 
reliability and the relationship of this information to human risk. EPA 
has also considered available information concerning the variability of 
the sensitivities of major identifiable subgroups of consumers, 
including infants and children. The nature of the toxic effects caused 
by these 2 isopropylamine salts of alkyl C4 and alkyl 
C8- 10 ethoxyphosphate esters are discussed in this unit.

A. Submitted Studies

    The petitioner has also submitted supporting toxicity information 
to the Agency which is summarized in Table 1.
    The acute toxicity profile is presented in Table 1.

  Table 1: Acute Toxicity Profile of 2 isopropylamine salts of alkyl C4 and alkyl C8	 10 ethoxyphosphate esters
----------------------------------------------------------------------------------------------------------------
                       Study                                       Result                        Category
----------------------------------------------------------------------------------------------------------------
Acute oral (Rats)                                                    LD50 > 2,000 mg/kg                      III
-----------------------------------------------------------------------------------------
Acute dermal (Rats)                                                  LD50 > 2,000 mg/kg                      III
-----------------------------------------------------------------------------------------
Eye irritation                                                      Slightly irritating                      III
-----------------------------------------------------------------------------------------
Dermal irritation (Rabbits)                                              Not irritating                      III
-----------------------------------------------------------------------------------------
Dermal sensitizer (GP)                                                 Not a sensitizer                       NA
----------------------------------------------------------------------------------------------------------------

    The petitioner also submitted the following mutagenicity assays, as 
described in Table 2:

                                  Table 2: Mutagenicity Assays Conducted Using:
----------------------------------------------------------------------------------------------------------------
                   Type of Assay                                Test Culture                     Results
----------------------------------------------------------------------------------------------------------------
Ames                                                   S. typhimurium TA 98, TA 100, TA                 Negative
                                                                  102, TA 1535, TA 1537
----------------------------------------------------------------------------------------------------------------

B. Structure Activity Relationship (SAR) Assessment

    Toxicity for these 2 isopropylamine salts of alkyl C4 
and alkyl C8- 10 ethoxyphosphate esters was assessed, in 
part, by a process called structure-activity relationship (SAR). In 
this process, the chemical's structural similarity to other chemicals 
(for which data are available) is used to determine toxicity. For human 
health, this process, can be used to assess absorption and metabolism, 
mutagenicity, carcinogenicity, developmental and reproductive effects, 
neurotoxicity, systemic effects, immunotoxicity, and sensitization and 
irritation. This is a qualitative assessment using terms such as good, 
not likely, poor, moderate, or high.
    The SAR conclusions for these 2 isopropylamine salts of alkyl 
C4 and alkyl C8- 10 ethoxyphosphate esters and 
several structurally related analogs were as follows: Absorption would 
be poor through the skin, good through the lungs, and moderate through 
the GI tract. Absorption of the amine will be good through the lungs 
and GI tract based on analogs. The SAR also indicated a concern for 
lung toxicity and irritation to mucous membranes if inhaled based on 
surfactancy. There is concern for neurotoxicity from the amine salt. No 
concerns for developmental or reproductive effects, carcinogenicity, or 
mutagenicity were noted. The overall rating for human health is low/ 
moderate concern.

C. Conclusions

    EPA has reviewed the toxicity data for these 2 isopropylamine salts 
of alkyl C4 and alkyl C8- 10 ethoxyphosphate 
esters and concludes as follows:
    The acute toxicity data demonstrated that these 2 isopropylamine 
salts of alkyl C4 and alkyl C8- 10 
ethoxyphosphate esters exhibited low acute toxicity, Category III, 
based on the Agency's rating of toxicity categories I through IV, 
highest to lowest. These 2 isopropylamine salts of alkyl C4 
and alkyl C8- 10 ethoxyphosphate esters are slight eye 
irritants. Other data reviewed by the Agency indicated that these two 
salts are not mutagenic.
    The SAR indicated that absorption would be poor through the skin, 
good through the lungs, and moderate through the GI tract. The SAR also

[[Page 31367]]

reflected the typical concerns for lung toxicity and irritation to 
mucous membranes if inhaled based on surfactancy. Such concerns are 
addressed by use of personal protection equipment as determined by end-
product acute inhalation testing, or by limitations on the amount of 
surfactant in a formulated pesticide. There are also typical concerns 
for neurotoxicity based on the inclusion of an amine salt in the 
chemical structure, and for lung toxicity and irritation to mucous 
membranes if inhaled based on surfactancy. As a chemical class amine 
salts are generally reported to have neurotoxic effects. However, there 
is an overall lack of documentation in the public literature to support 
a specific concern for neurotoxicity for isopropylamine salts. The SAR 
rated these two isopropylamine salts as low to moderate for human 
health concerns. This rating reflects the concerns associated with the 
irritation to mucous membranes commonly caused by surfactants.
    The SAT in OPPT (Office of Pollution Prevention and Toxics) has 
reviewed information on several surfactants. As a broad class of 
chemicals surfactants are often corrosive and irritating to mucous 
membranes. These properties make animal toxicity testing of surfactants 
difficult, and require interpretation of the test results as to whether 
the effects are attributed to the corrosive/irritant effects or other 
mechanisms of toxicity.
    Based on the SAR assessment, the review and evaluation of the 
submitted data, and given the Agency's understanding of the 
toxicological properties of surfactants, EPA concludes that these 2 
isopropylamine salts of alkyl C4 and alkyl C8- 10 
ethoxyphosphate esters are of lower toxicity. There is a concern for 
corrosive/irritation effects of these 2 isopropylamine salts of alkyl 
C4 and alkyl C8- 10 ethoxyphosphate esters. Based 
on these concerns which are those of surfactants as a class, EPA is 
requiring a limitation on the use of these 2 isopropylamine salts of 
alkyl C4 and alkyl C8- 10 ethoxyphosphate esters, 
not to exceed 15% in the formulated product. Based on previously 
conducted quantitative and qualitative risk assessments on related 
surfactant chemicals which the Agency has exempted from the requirement 
of a tolerance, the Agency believes that this limitation is 
sufficiently protective for the corrosive effects common to the 
surfactancy of these two salts.

V. Aggregate Exposures

    In examining aggregate exposure, section 408 of the FFDCA directs 
EPA to consider available information concerning exposures from the 
pesticide residue in food and all other non-occupational exposures, 
including drinking water from ground water or surface water and 
exposure through pesticide use in gardens, lawns, or buildings 
(residential and other indoor uses).
    EPA establishes exemptions from the requirement of a tolerance only 
in those cases where it can be clearly demonstrated that the risks from 
aggregate exposure to pesticide chemical residues under reasonably 
foreseeable circumstances will pose no appreciable risks to human 
health. In order to determine the risks from aggregate exposure to 
pesticide inert ingredients, the Agency considers the toxicity of the 
inert in conjunction with possible exposure to residues of the inert 
ingredient through food, drinking water, and through other exposures 
that occur as a result of pesticide use in residential settings. If EPA 
is able to determine that a finite tolerance is not necessary to ensure 
that there is a reasonable certainty that no harm will result from 
aggregate exposure to the inert ingredient, an exemption from the 
requirement of a tolerance may be established.
    1. Dietary exposure -- Food. In order to assess dietary exposure 
the Agency considered that these two isopropylamine salts could be 
present in all raw and processed agricultural commodities. The Agency 
has estimated a generic dietary exposure estimate for an inert 
ingredient of 0.12 milligrams/kilogram/day (mg/kg/day). To assure that 
the exposure is not underestimated, it is assumed that the inert 
ingredients are used on all crops and 100% of all crops are ``treated'' 
with the inert ingredient. The generic dietary exposure estimate is 
based on an application rate of 5 pounds per acre. Information from the 
petitioner indicates that the anticipated use rate of these 2 
isopropylamine salts of alkyl C4 and alkyl C8- 10 
ethoxyphosphate esters is expected to be much less than one pound per 
acre. The expected dietary exposure estimate would therefore be 
considerably less than 0.024 mg/kg/day. Given the low levels of 
exposure and the low systemic toxicity of these 2 isopropylamine salts 
of alkyl C4 and alkyl C8- 10 ethoxyphosphate 
esters, the concern for risk to human health is low.
    2. Drinking water. Based on its biodegradation models, the Agency 
estimated that the time for complete ultimate biodegradation is weeks 
to months. There is also strong to very strong sorption to soils and 
sediments. Due to the strong adherence to soils and sediments, and 
ready biodegradation the substances would only be minimally available 
in surface waters. Thus, only low drinking water exposure is expected, 
and the concern for risk to human health is low.

VI. Cumulative Effects

    Section 408 (b)(2)(D)(v) of FFDCA requires that, when considering 
whether to establish, modify, or revoke a tolerance or tolerance 
exemption, the Agency consider ``available information'' concerning the 
cumulative effects of a particular chemical's residues and ``other 
substances that have a common mechanism of toxicity.''
    Unlike other pesticide chemicals for which EPA has followed a 
cumulative risk approach based on a common mechanism of toxicity, EPA 
has not made a common mechanism of toxicity finding as to these 2 
isopropylamine salts of alkyl C4 and alkyl C8- 10 
ethoxyphosphate esters and any other substances. These 2 isopropylamine 
salts of alkyl C4 and alkyl C8- 10 
ethoxyphosphate esters do not appear to produce a toxic metabolite 
produced by other substances. For the purposes of this tolerance 
action, therefore, EPA has not assumed that these 2 isopropylamine 
salts of alkyl C4 and alkyl C8- 10 
ethoxyphosphate esters have a common mechanism of toxicity with other 
substances. For information regarding EPA's efforts to determine which 
chemicals have a common mechanism of toxicity and to evaluate the 
cumulative effects of such chemicals, see the policy statements 
released by EPA's Office of Pesticide Programs concerning common 
mechanism determinations and procedures for cumulating effects from 
substances found to have a common mechanism on EPA's website at http://www.epa.gov/pesticides/cumulative/.

VII. Safety Factor for the Protection of Infants and Children

    FFDCA section 408 provides that EPA shall apply an additional 
tenfold margin of safety for infants and children in the case of 
threshold effects to account for prenatal and postnatal toxicity and 
the completeness of the data unless EPA concludes that a different 
margin of safety will be safe for infants and children. For 2 
isopropylamine salts of alkyl C4 and alkyl C8- 10 
ethoxyphosphate esters, the SAR did not identify any concerns for 
developmental or reproductive toxicity. The identified concerns for 2 
isopropylamine salts of alkyl C4 and alkyl C8- 10 
ethoxyphosphate esters are corrosion/irritation. EPA has not used a 
safety factor analysis to assess the risk.

[[Page 31368]]

 For the same reasons a tenfold safety factor is unnecessary.

VIII. Determination of Safety for U.S. Population

    Based on the information in this preamble, EPA concludes that there 
is a reasonable certainty of no harm from aggregate exposure to 
residues of 2 isopropylamine salts of alkyl C4 and alkyl 
C8- 10 ethoxyphosphate esters, and that under reasonably 
foreseeable circumstances aggregate exposure to 2 isopropylamine salts 
of alkyl C4 and alkyl C8- 10 ethoxyphosphate 
esters will pose no appreciable risk to human health. Accordingly, EPA 
finds that exempting 2-Propanamine, compound with [alpha]-phosphono -
[omega]- butoxypoly (oxy-1,2-ethanediyl) (2:1) (CAS Reg. No. 43140-31-
2)and 2-Propanamine, compounds with polyethylene glycol dihydrogen 
phosphate C8- 10- alkyl ether (2:1) (CAS Reg. No. 431062-72-
5) from the requirement of a tolerance will be safe for the general 
population including infants and children.

IX. Other Considerations

A. Endocrine Disruptors

    FQPA requires EPA to develop a screening program to determine 
whether certain substances, including all pesticide chemicals (both 
inert and active ingredients), ``may have an effect in humans that is 
similar to an effect produced by a naturally occurring estrogen, or 
such other endocrine effect . . .'' EPA has been working with 
interested stakeholders to develop a screening and testing program as 
well as a priority setting scheme. As the Agency proceeds with 
implementation of this program, further testing of these products, 2 
isopropylamine salts of alkyl C4 and alkyl C8- 10 
ethoxyphosphate esters, for endocrine effects may be required.

B. Analytical Method(s)

    An analytical method is not required for enforcement purposes since 
the Agency is establishing an exemption from the requirement of a 
tolerance without any numerical limitation.

C. Existing Exemptions

    There are no existing tolerances or tolerance exemptions for these 
2 isopropylamine salts of alkyl C4 and alkyl 
C8- 10 ethoxyphosphate esters.

D. International Tolerances

    The Agency is not aware of any country requiring a tolerance for 
these 2 isopropylamine salts of alkyl C4 and alkyl 
C8- 10 ethoxyphosphate esters nor have any CODEX Maximum 
Residue Levels (MRLs) been established for any food crops at this time.

X. Conclusions

    Therefore, an exemption from the requirement for a tolerance is 
established for 2-Propanamine, compound with [alpha]-phosphono -
[omega]- butoxypoly (oxy-1,2-ethanediyl) (2:1) (CAS Reg. No. 43140-31-
2) and 2-Propanamine, compounds with polyethylene glycol dihydrogen 
phosphate C8- 10- alkyl ether (2:1) (CAS Reg. No. 431062-72-
5).

XI. Objections and Hearing Requests

    Under section 408(g) of the FFDCA, as amended by the FQPA, any 
person may file an objection to any aspect of this regulation and may 
also request a hearing on those objections. The EPA procedural 
regulations which govern the submission of objections and requests for 
hearings appear in 40 CFR part 178. Although the procedures in those 
regulations require some modification to reflect the amendments made to 
the FFDCA by the FQPA, EPA will continue to use those procedures, with 
appropriate adjustments, until the necessary modifications can be made. 
The new section 408(g) of the FFDCA provides essentially the same 
process for persons to ``object'' to a regulation for an exemption from 
the requirement of a tolerance issued by EPA under new section 408(d) 
of the FFDCA, as was provided in the old FFDCA sections 408 and 409 of 
the FFDCA. However, the period for filing objections is now 60 days, 
rather than 30 days.

A. What Do I Need to Do to File an Objection or Request a Hearing?

    You must file your objection or request a hearing on this 
regulation in accordance with the instructions provided in this unit 
and in 40 CFR part 178. To ensure proper receipt by EPA, you must 
identify docket ID number OPP-2005-0115 in the subject line on the 
first page of your submission. All requests must be in writing, and 
must be mailed or delivered to the Hearing Clerk on or before August 1, 
2005.
    1. Filing the request. Your objection must specify the specific 
provisions in the regulation that you object to, and the grounds for 
the objections (40 CFR 178.25). If a hearing is requested, the 
objections must include a statement of the factual issues(s) on which a 
hearing is requested, the requestor's contentions on such issues, and a 
summary of any evidence relied upon by the objector (40 CFR 178.27). 
Information submitted in connection with an objection or hearing 
request may be claimed confidential by marking any part or all of that 
information as CBI. Information so marked will not be disclosed except 
in accordance with procedures set forth in 40 CFR part 2. A copy of the 
information that does not contain CBI must be submitted for inclusion 
in the public record. Information not marked confidential may be 
disclosed publicly by EPA without prior notice.
    Mail your written request to: Office of the Hearing Clerk (1900L), 
Environmental Protection Agency, 1200 Pennsylvania Ave., NW., 
Washington, DC 20460-0001. You may also deliver your request to the 
Office of the Hearing Clerk in Suite 350, 1099 14th St., NW., 
Washington, DC 20005. The Office of the Hearing Clerk is open from 8 
a.m. to 4 p.m., Monday through Friday, excluding legal holidays. The 
telephone number for the Office of the Hearing Clerk is (202) 564-6255.
    2. Copies for the Docket. In addition to filing an objection or 
hearing request with the Hearing Clerk as described in Unit XI.A., you 
should also send a copy of your request to the PIRIB for its inclusion 
in the official record that is described in ADDRESSES. Mail your 
copies, identified by docket ID number OPP-2005-0115, to: Public 
Information and Records Integrity Branch, Information Resources and 
Services Division (7502C), Office of Pesticide Programs, Environmental 
Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-
0001. In person or by courier, bring a copy to the location of the 
PIRIB described in ADDRESSES. You may also send an electronic copy of 
your request via e-mail to: [email protected]. Please use an ASCII 
file format and avoid the use of special characters and any form of 
encryption. Copies of electronic objections and hearing requests will 
also be accepted on disks in WordPerfect 6.1/8.0 or ASCII file format. 
Do not include any CBI in your electronic copy. You may also submit an 
electronic copy of your request at many Federal Depository Libraries.

B. When Will the Agency Grant a Request for a Hearing?

    A request for a hearing will be granted if the Administrator 
determines that the material submitted shows the following: There is a 
genuine and substantial issue of fact; there is a reasonable 
possibility that available evidence identified by the requestor would, 
if established resolve one or more of such issues in favor of the 
requestor, taking into account uncontested claims or facts to the 
contrary; and resolution of the factual issues(s) in the manner sought 
by the requestor would be adequate to justify the action requested (40 
CFR 178.32).

[[Page 31369]]

XII. Statutory and Executive Order Reviews

    This final rule establishes an exemption from the tolerance 
requirement under section 408(d) of the FFDCA in response to a petition 
submitted to the Agency. The Office of Management and Budget (OMB) has 
exempted these types of actions from review under Executive Order 
12866, entitled Regulatory Planning and Review (58 FR 51735, October 4, 
1993). Because this rule has been exempted from review under Executive 
Order 12866 due to its lack of significance, this rule is not subject 
to Executive Order 13211, Actions Concerning Regulations That 
Significantly Affect Energy Supply, Distribution, or Use (66 FR 28355, 
May 22, 2001). This final rule does not contain any information 
collections subject to OMB approval under the Paperwork Reduction Act 
(PRA), 44 U.S.C. 3501 et seq., or impose any enforceable duty or 
contain any unfunded mandate as described under Title II of the 
Unfunded Mandates Reform Act of 1995 (UMRA) (Public Law 104-4). Nor 
does it require any special considerations under Executive Order 12898, 
entitled Federal Actions to Address Environmental Justice in Minority 
Populations and Low-Income Populations (59 FR 7629, February 16, 1994); 
or OMB review or any Agency action under Executive Order 13045, 
entitled Protection of Children from Environmental Health Risks and 
Safety Risks (62 FR 19885, April 23, 1997). This action does not 
involve any technical standards that would require Agency consideration 
of voluntary consensus standards pursuant to section 12(d) of the 
National Technology Transfer and Advancement Act of 1995 (NTTAA), 
Public Law 104-113, section 12(d) (15 U.S.C. 272 note). Since 
tolerances and exemptions that are established on the basis of a 
petition under section 408(d) of the FFDCA, such as the exemption in 
this final rule, do not require the issuance of a proposed rule, the 
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et 
seq.) do not apply. In addition, the Agency has determined that this 
action will not have a substantial direct effect on States, on the 
relationship between the national government and the States, or on the 
distribution of power and responsibilities among the various levels of 
government, as specified in Executive Order 13132, entitled Federalism 
(64 FR 43255, August 10, 1999). Executive Order 13132 requires EPA to 
develop an accountable process to ensure ``meaningful and timely input 
by State and local officials in the development of regulatory policies 
that have federalism implications.'' ``Policies that have federalism 
implications'' is defined in the Executive Order to include regulations 
that have ``substantial direct effects on the States, on the 
relationship between the national government and the States, or on the 
distribution of power and responsibilities among the various levels of 
government.'' This final rule directly regulates growers, food 
processors, food handlers and food retailers, not States. This action 
does not alter the relationships or distribution of power and 
responsibilities established by Congress in the preemption provisions 
of section 408(n)(4) of the FFDCA. For these same reasons, the Agency 
has determined that this rule does not have any ``tribal implications'' 
as described in Executive Order 13175, entitled Consultation and 
Coordination with Indian Tribal Governments (65 FR 67249, November 6, 
2000). Executive Order 13175, requires EPA to develop an accountable 
process to ensure ``meaningful and timely input by tribal officials in 
the development of regulatory policies that have tribal implications.'' 
``Policies that have tribal implications'' is defined in the Executive 
Order to include regulations that have ``substantial direct effects on 
one or more Indian tribes, on the relationship between the Federal 
Government and the Indian tribes, or on the distribution of power and 
responsibilities between the Federal Government and Indian tribes.'' 
This rule will not have substantial direct effects on tribal 
governments, on the relationship between the Federal Government and 
Indian tribes, or on the distribution of power and responsibilities 
between the Federal Government and Indian tribes, as specified in 
Executive Order 13175. Thus, Executive Order 13175 does not apply to 
this rule.

XIII. Congressional Review Act

    The Congressional Review Act, 5 U.S.C. 801 et seq., as added by the 
Small Business Regulatory Enforcement Fairness Act of 1996, generally 
provides that before a rule may take effect, the agency promulgating 
the rule must submit a rule report, which includes a copy of the rule, 
to each House of the Congress and to the Comptroller General of the 
United States. EPA will submit a report containing this rule and other 
required information to the U.S. Senate, the U.S. House of 
Representatives, and the Comptroller General of the United States prior 
to publication of this final rule in the Federal Register. This final 
rule is not a ``major rule'' as defined by 5 U.S.C. 804(2).

List of Subjects in 40 CFR Part 180

    Environmental protection, Administrative practice and procedure, 
Agricultural commodities, Pesticides and pests, Reporting and 
recordkeeping requirements.

    Dated: May 20, 2005.
Lois Rossi,
Director, Registration Division, Office of Pesticide Programs.

0
Therefore, 40 CFR chapter I is amended as follows:

PART 180--[AMENDED]

0
1. The authority citation for part 180 continues to read as follows:

    Authority: 21 U.S.C. 321(q), 346a and 371.

0
2. In Sec.  180.920, the table is amended by adding alphabetically the 
following inert ingredients to read as follows:


Sec.  180.920   Inert ingredients used pre-harvest; exemptions from the 
requirement of a tolerance.

* * * * *

------------------------------------------------------------------------
        Inert ingredients               Limits               Uses
------------------------------------------------------------------------
                              * * * * * * *
2-Propanamine, compound with      Not more than 15%   Surfactant
 [alpha]-phosphono -[omega]-       in the formulated
 butoxypoly (oxy-1,2-ethanediyl)   product.
 (2:1) (CAS Reg. No. 43140-31-2).
2-Propanamine, compounds with     Not more than 15%   Surfactant
 polyethylene glycol dihydrogen    in the formulated
 phosphate C8	 10- alkyl ether     product.
 (2:1) (CAS Reg. No. 431062-72-
 5).
                              * * * * * * *
------------------------------------------------------------------------


[[Page 31370]]

* * * * *
[FR Doc. 05-10845 Filed 5-31-05; 8:45 am]
BILLING CODE 6560-50-S